Skip to content
GoKawiil
Tech News
← Back to articles
Revolution Medicines Draws Takeover Interest
2026-01-07 |
original
read original
get Medicines →
more articles
The cancer-drug biotech firm has a market value around $20 billion.
Explore topics:
billion
biotech
biotech firm
cancer
cancer drug
Related:
Show HN: Open-source engine running Gemma 4 26B in 2 GB RAM on any M-series Mac
Relapsed childhood cancers show genomic scars left by previous therapy
Doctors say this everyday drink could cut your liver cancer risk by 47%
Johnson & Johnson offers $5.5 billion to settle remaining lawsuits over talc products linked to cancer
As US measles cases rise, biotech firms start developing new treatments
Get alerts for these topics
billion
biotech
biotech firm
cancer
cancer drug
Subscribe
We'll send a verification email. No spam.